BMS Elects New CEO

May 23, 2007
BioPharm International Editors

James M. Cornelius, who has served as interim chief executive for the past eight months, has been elected chief executive officer of Bristol-Myers Squibb Company (New York, NY, www.bms.com) with a term through the date of the company's annual meeting of stockholders in 2009.

James M. Cornelius, who has served as interim chief executive for the past eight months, has been elected chief executive officer of Bristol-Myers Squibb Company (New York, NY, www.bms.com) with a term through the date of the company’s annual meeting of stockholders in 2009. Cornelius has been a member of the BMS board since January 2007. Before joining BMS, he was the chief financial officer of Eli Lilly and Company.

Related Content:

News